H2BC12L and cancer: Reversible epigenetics modifications sustain nonmutational epigenetic reprogramming, including DNA hypo- or/and hypermethylation, PTMs of proteins, including histone and non-histone proteins, and noncoding RNAs (ncRNAs) affect gene expression in cancer cells by alteration of chromatin and DNA accessibility without changes on DNA sequences.